The Daily Activity Report (DAR) a Novel Measure of Functional Outcome for Serious Mental Illness
Dawn I. Velligan(The University of Texas at San Antonio Health Science Center), Patricia K. Corey‐Lisle(Eli Lilly (United States)), Gregory A. Maglinte(Bristol-Myers Squibb (United States)), Cynthia Sierra, Jim Mintz(The University of Texas at San Antonio Health Science Center), Megan Fredrick(The University of Texas at San Antonio Health Science Center), Mona L. Martin(Dermatology Associates of Seattle)
Cited by 10
Related Papers
Nivolumab in patients with metastatic DNA mismatch repair-deficient or microsatellite instability-high colorectal cancer (CheckMate 142): an open-label, multicentre, phase 2 study
|The Lancet Oncology|2017|2.8k
Self-report measures of medication adherence behavior: recommendations on optimal use
|Translational Behavioral Medicine|2015|832
Beyond hypofrontality: A quantitative meta‐analysis of functional neuroimaging studies of working memory in schizophrenia
|Human Brain Mapping|2005|622
The expert consensus guideline series: adherence problems in patients with serious and persistent mental illness.
|PubMed|2009|611
Why do psychiatric patients stop antipsychotic medication? A systematic review of reasons for nonadherence to medication in patients with serious mental illness
|Patient Preference and Adherence|2017|325